معرفی
Anders Valind is a researcher at Lund University's Department of Clinical Genetics and is affiliated with the Lund University Cancer Center (LUCC). Holding both MD and PhD degrees, he contributes to cancer research with a focus on tumor heterogeneity and evolution. His work spans multiple collaborative projects within the university's medical research ecosystem.
Dr. Valind's primary research interests center on tumor cell heterogeneity and evolution within individual tumors, examining both biological mechanisms and clinical implications. His work particularly investigates intra-tumor evolution in genomic and clinical contexts, with additional focus on somatic mosaicism and its role in disease development. His research spans pediatric cancers, especially neuroblastoma and Wilms tumor, where he applies evolutionary biology principles to understand cancer progression and treatment resistance. His fingerprint analysis reveals strong expertise in Wilms' Tumor (100%), Aneuploidy (93%), Genetics (86%), Ganglioneuroblastoma (78%), Evolution (76%), Phylogeny (69%), Chromosome (60%), and Genetic Variation (52%).
Analysis of his recent publications shows a consistent focus on tumor evolution across spatial domains, particularly in pediatric cancers. His work integrates genomic analysis with clinical observations to understand how tumors evolve during treatment, with particular attention to chemotherapy resistance mechanisms. The research demonstrates interdisciplinary approaches combining genomics, pathology, and clinical oncology to address fundamental questions about cancer progression.
- Oskar IIs stipendium (2018-04-16)
- Anna-Greta Crafoords pris (2018-04-12)
Dr. Valind serves as a co-supervisor on doctoral projects including 'Phylogenetic analysis of pediatric tumors' (2020-2024) and 'Affektanfall i södra Sverige' studying demographics, diagnostics, and iron substitution treatment. He actively participates in LUCC activities, including the 'Clinical and Scientific Challenges' workshop scheduled for 2025. His collaborative network spans multiple research groups within Lund University, particularly connecting cancer genetics with clinical oncology.
As part of the Lund University Cancer Center, Dr. Valind works within a multidisciplinary team focused on cancer genetics and tumor evolution. His research contributes to LUCC's mission of advancing cancer research through integration of basic science and clinical applications, particularly in the realm of pediatric oncology where understanding tumor evolution has direct implications for treatment strategies.
